Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 14,668 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Milestone Pharmaceuticals Inc | MIST | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.39 | 09:33:32 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1.38 | 1.3787 | 1.40 | 1.39 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 52 | 14,668 | US$ 1.38 | US$ 20,296 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 09:44:00 | 14 | US$ 1.3739 | USD |
Información Financiera Milestone Pharmaceuticals Inc MIST
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 46.21M | 33.48M | - | 1M | -59.69M | -1.78 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Milestone Pharmaceuticals Inc MIST
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 29/5/2024 | 06:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/5/2024 | 07:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Partners with Arrhythmia Alliance.. |
| 13/5/2024 | 06:34 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/5/2024 | 05:59 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 04/3/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01/3/2024 | 15:52 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 29/2/2024 | 06:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Pricing of $30.0 Million.. |
| 28/2/2024 | 15:37 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Proposed Public Offering.. |
| 26/2/2024 | 06:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/2/2024 | 19:56 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 14/2/2024 | 06:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 26/12/2023 | 07:54 | Dow Jones News | Milestone Pharmaceuticals Shares Sink 24% After Receiving.. |
Histórico de Datos MIST
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
